A new rapid nasal swab test accurately identifies asthma subtypes in children by analyzing genes linked to immune cells causing inflammation. This non-invasive method replaces invasive procedures, enabling more targeted treatments, particularly for T2-high asthma, and advancing research on other subtypes.
